Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
13.01.26
/
50%
€58.38
Target price
13.01.27
€94.35
Performance (%)
-9.59%
Price
26.03.26
€52.78
Summary
This prediction is currently active. With a performance of -9.59%, the BUY prediction by Piper_Sandler is trending in the wrong direction. This prediction currently runs until 13.01.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 7.386% | 7.386% |
| iShares Core DAX® | -1.742% | -10.677% |
| iShares Nasdaq 100 | -2.583% | -3.319% |
| iShares Nikkei 225® | -1.165% | -9.362% |
| iShares S&P 500 | -1.422% | -3.762% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€55.98
17.12.25
17.12.25
€85.13
17.12.26
17.12.26
-5.72%
26.03.26
26.03.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
54.60%
26.03.26
26.03.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25